Green Cross Corporation Logo

Green Cross Corporation

006280 | KO

Overview

Corporate Details

ISIN(s):
KR7006280002
LEI:
Country:
South Korea
Address:
경기도 용인시 기흥구 이현로30번길 107(보정동), 용인시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

No description available.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-22 00:00
Regulatory Filings
[기재정정]단일판매ㆍ공급계약체결
Korean 13.2 KB
2025-08-14 00:00
Interim / Quarterly Report
반기보고서 (2025.06)
Korean 4.2 MB
2025-08-05 00:00
Governance Information
공정거래자율준수프로그램운영현황(안내공시)
Korean 25.5 KB
2025-08-01 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 15.0 KB
2025-06-02 00:00
Governance Information
기업지배구조보고서공시
Korean 4.2 MB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 3.2 MB
2025-04-30 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 15.0 KB
2025-04-08 00:00
Regulatory Filings
투자판단관련주요경영사항
Korean 8.5 KB
2025-04-08 00:00
Management Reports
[기재정정]장래사업ㆍ경영계획(공정공시)
Korean 14.0 KB
2025-03-31 00:00
Management Reports
[기재정정]장래사업ㆍ경영계획(공정공시)
Korean 11.7 KB
2025-03-27 00:00
Major Shareholding Notification
최대주주등소유주식변동신고서
Korean 50.2 KB
2025-03-26 00:00
AGM Information
정기주주총회결과
Korean 19.8 KB
2025-03-18 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 717.7 KB
2025-03-18 00:00
Audit Report / Information
감사보고서제출
Korean 19.6 KB
2025-03-13 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.8 KB

Automate Your Workflow. Get a real-time feed of all Green Cross Corporation filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Green Cross Corporation

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Green Cross Corporation via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

A global CDEMO offering end-to-end solutions for antibody therapeutics and biologics.
South Korea
334970
Develops affordable biosimilars and novel antibody drugs for life-threatening diseases.
Singapore
950210
Prestige Consumer Healthcare Inc. Logo
Develops and markets leading over-the-counter brands for personal healthcare and wellness.
United States of America
PBH
Prime Medicine, Inc. Logo
Developing 'search and replace' gene editing therapies to treat genetic disorders.
United States of America
PRME
Probi Logo
Develops and manufactures clinically proven probiotics for B2B supplement & nutrition partners.
Sweden
PROB
Develops scientifically validated probiotics for cardiometabolic health for consumers & partners.
United Kingdom
PBX
Processa Pharmaceuticals, Inc. Logo
Develops next-gen chemo and therapies for chronic and life-threatening diseases.
United States of America
PCSA
Develops protein-based immunotherapies for metabolic diseases, immune disorders, and cancer.
South Korea
296160
PROKIDNEY CORP. Logo
Develops cellular therapies to preserve kidney function for patients with advanced Chronic Kidney Disease.
United States of America
PROK
ProPhase Labs, Inc. Logo
Genomics, diagnostics, contract manufacturing, and OTC health & wellness solutions provider.
United States of America
PRPH

Talk to a Data Expert

Have a question? We'll get back to you promptly.